ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,173.02
0.64%
Dow Jones
42,544.22
-0.07%
Gold vs US Dollar
2,625.73
0.06%
Brent Oil
73.855
0.00%
Bitcoin
94,781.65
0.41%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Arch Biopartners Inc (ARCH) Share Price

ARCH Arch Biopartners Inc

1.93
0.09 (4.89%)
31 Dec 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Arch Biopartners Inc TSXV:ARCH TSX Venture Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.09 4.89 1.93 1.93 1.94 1.94 1.85 1.88 12,800 20:59:59   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Coml Physical, Biologcl Resh 1.98M -3.33M -0.0531 -36.35 115.18M
 Type  Size  Price  Time  Units 
  200 1.93 20:59:59 CAD
 
Recent News
DateTimeSource
HeadlineMore ARCH News
11/11/202418:46APSDosing of First Patient in a Trial for LSALT Peptide is Sending Shares HIgher
11/11/202412:30GLOBEArch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
15/10/202422:23GLOBEArch Biopartners Arranges Non-Brokered Private Placement
03/10/202411:45GLOBECloses Units for Debt Settlement
26/09/202412:46GLOBEUnits for Debt Settlement
11/09/202410:30GLOBEArch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
02/08/202411:20GLOBEArch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
18/11/201413:40PBBARC Capital Holdings Ltd.13
07/01/200914:53PBBLord ARCHER - Fangelsets Porrkung5


Loading Follow Feed...

Latest Arch Biopartners Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads